Trial · NCT00033657
Adverse events380
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 380
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Neoadjuvant_Cisplatin / Irinotecan / RT (Arm A) | 38 | 47 | |
| other | Anemia | Blood and lymphatic system disorders | Neoadjuvant_Paclitaxel / Cisplatin / RT (Arm B) | 40 | 46 | |
| other | Anemia | Blood and lymphatic system disorders | Adjuvant_Cisplatin / Irinotecan / RT ( Arm A) | 28 | 31 | |
| other | Anemia | Blood and lymphatic system disorders | Adjuvant_Paclitaxel / Irinotecan / RT ( Arm B) | 22 | 27 | |
| other | Leukopenia | Investigations | Neoadjuvant_Cisplatin / Irinotecan / RT (Arm A) | 44 | 47 | |
| other | Leukopenia | Investigations | Neoadjuvant_Paclitaxel / Cisplatin / RT (Arm B) | 41 | 46 | |
| other | Leukopenia | Investigations | Adjuvant_Cisplatin / Irinotecan / RT ( Arm A) | 27 | 31 | |
| other | Leukopenia | Investigations | Adjuvant_Paclitaxel / Irinotecan / RT ( Arm B) | 17 | 27 | |
| other | Neutropenia | Investigations | Neoadjuvant_Cisplatin / Irinotecan / RT (Arm A) | 35 | 47 | |
| other | Neutropenia | Investigations | Neoadjuvant_Paclitaxel / Cisplatin / RT (Arm B) | 24 | 46 | |
| other | Neutropenia | Investigations | Adjuvant_Cisplatin / Irinotecan / RT ( Arm A) | 23 | 31 | |
| other | Neutropenia | Investigations | Adjuvant_Paclitaxel / Irinotecan / RT ( Arm B) | 9 | 27 | |
| other | Thrombocytopenia | Investigations | Neoadjuvant_Cisplatin / Irinotecan / RT (Arm A) | 31 | 47 | |
| other | Thrombocytopenia | Investigations | Neoadjuvant_Paclitaxel / Cisplatin / RT (Arm B) | 29 | 46 | |
| other | Thrombocytopenia | Investigations | Adjuvant_Cisplatin / Irinotecan / RT ( Arm A) | 21 | 31 | |
| other | Thrombocytopenia | Investigations | Adjuvant_Paclitaxel / Irinotecan / RT ( Arm B) | 8 | 27 | |
| other | Edema | General disorders | Neoadjuvant_Cisplatin / Irinotecan / RT (Arm A) | 1 | 47 | |
| other | Edema | General disorders | Neoadjuvant_Paclitaxel / Cisplatin / RT (Arm B) | 4 | 46 | |
| other | Edema | General disorders | Adjuvant_Cisplatin / Irinotecan / RT ( Arm A) | 1 | 31 | |
| other | Edema | General disorders | Adjuvant_Paclitaxel / Irinotecan / RT ( Arm B) | 0 | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00033657/events